Quick Summary
Prickly Lettuce (Lactuca serriola) is a widely distributed plant species that belongs to the same genus as common lettuce. It has been studied in botanical, ecological, and agricultural contexts, with some emerging research highlighting its potential to enhance natural rubber production. Extracts of the plant have also been evaluated for antioxidant properties relevant to cosmetic ingredient development. However, there is limited direct human clinical evidence regarding its medicinal benefits, safety profile, or drug interactions.
What Is It?
Lactuca serriola, commonly known as Prickly Lettuce, is a wild plant species found in various regions worldwide. It is recognized botanically for its characteristic prickly leaves and is related to the common cultivated lettuce. The plant has been the subject of agricultural and ecological studies but remains underexplored for direct therapeutic uses in humans.
Traditional Uses
Although Prickly Lettuce has a history as a wild edible and possibly medicinal plant, documented traditional uses lack rigorous scientific evaluation. It has not been widely established in traditional medicine systems with well-defined therapeutic roles.
Active Compounds
Lactuca serriola contains bioactive flavonoids such as apigenin and quercetin, compounds commonly found in the Lactuca genus. These flavonoids have been studied for various biological activities, including potential cardioprotective effects, though their presence and activity specifically in Prickly Lettuce require further clinical validation.
Potential Benefits with Evidence Levels
- Natural rubber production enhancement
Evidence Level: Preclinical (plant-based experimental study)
A 2024 study demonstrated that foliar application of methyl jasmonate in Lactuca serriola increased the expression of key rubber biosynthesis genes and enhanced rubber content and molecular weight in the plant latex. (Asheri et al., 2024) - Potential source of bioactive compounds relevant to cardioprotection
Evidence Level: Indirect – chemical/pharmacological review
Lactuca serriola contains flavonoids such as apigenin and quercetin, which have been reviewed for cardioprotective properties in experimental and clinical contexts, although direct clinical evidence specific to Lactuca serriola is lacking. (Tomou et al., 2023) - Antioxidant potential in cosmetic applications
Evidence Level: In vitro phytochemical profiling
Screening of plants in France included Lactuca serriola among candidates for cosmetic ingredient development due to antioxidant bioassays, without clinical validation. (Viéytez et al., 2025)
Side Effects
There are no documented adverse effects or toxicity reports related to Lactuca serriola in humans from clinical trials or case studies. The plant is generally considered a wild species with no known safety concerns documented in medical literature.
Drug Interactions
No information is available regarding drug interactions involving Lactuca serriola based on current scientific literature.
Who Should Avoid It?
No clinically documented contraindications exist for the use of Prickly Lettuce. However, due to the lack of safety data, caution is advised for pregnant or breastfeeding individuals, and those considering its use for medicinal purposes should consult healthcare providers.
Evidence Limitations
- There are no human clinical trials or randomized controlled trials assessing safety or efficacy for any therapeutic use of Lactuca serriola.
- Evidence predominantly comes from preclinical plant-based studies, phytochemical profiling, or ethnobotanical reports without direct clinical validation.
- No systematic reviews or meta-analyses evaluate clinical outcomes related to this herb.
- Data on dosing, safety, pharmacokinetics, and pharmacodynamics in humans are lacking.
- Traditional uses exist but are not supported by rigorous scientific clinical evidence.
References
- Asheri M, Farokhzad A, Naghavi MR, Ghasemzadeh R, Azadi P, Zargar M. (2024). Methyl jasmonate improves rubber production and quality in Lactuca serriola. Europe PMC. doi:10.1038/s41598-024-78065-3.
- Tomou EM, Papakyriakopoulou P, Skaltsa H, Valsami G, Kadoglou NPE. (2023). Bio-Actives from Natural Products with Potential Cardioprotective Properties: Isolation, Identification, and Pharmacological Actions of Apigenin, Quercetin, and Silibinin. Europe PMC. doi:10.3390/molecules28052387.
- Viéytez M, Robert-Hazotte A, Thomas A, Nardello-Rataj V, Fernandez X. (2025). A Workflow for Selecting, Profiling, and Optimizing Plant Extracts for Cosmetic Applications. Europe PMC. doi:10.1002/cbdv.202502397.
Last Reviewed
June 2024
Disclaimer: This information is provided for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before using any herbal products, especially if you are pregnant, breastfeeding, have existing medical conditions, or are taking medications.